access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Letter of Intent for Corporate Clinical Research Regulatory Fees

 SOP: ORSP 101

Letter of Intent (LOI) for Regulatory & Compliance Review Fees and Regulatory & Compliance Document Submission Preparation Fees

Version No.:2

Effective Date: February 26, 2019

Supersedes Document: September 17, 2015

1. Procedure

The purpose of this procedure is:

a) to ensure that MUSC research teams are compensated for the time and effort associated with preparation and initial submission of IRB documents and other regulatory submission, including Office of Clinical Research (OCR) Prospective Reimbursement Analysis (PRA);
b) to ensure that Institutional Review Board (IRB) and OCR PRA initial review fees are paid for by the sponsor; and
c) to improve MUSC research team efficiency by enabling budget and Clinical Trial Agreement (CTA) negotiations and regulatory and compliance submissions to occur in parallel.

2. Scope

This SOP defines the process approved at the Medical University of South Carolina (MUSC) for executing a Letter of Intent (LOI) between MUSC and the study Funding Entity in order to implement budget negotiations and regulatory and research billing compliance submissions in parallel.

3. Responsibility

General administration: MUSC Office of Research and Sponsored Programs
Specific studies: MUSC Principal Investigator’s Department, Office of Clinical Research Finance Team

4. Applicable Regulations and Guidelines

As with any agreement, ORSP will not sign an LOI until the electronic proposal is routed and approved by the Department.
Any changes to LOI language must be reviewed and approved by ORSP.

5. SOP Attachments

ORSP 101-A: Authorization for Regulatory / Research Billing Compliance Review Fees and Research Team Preparation of Regulatory & Compliance Submission Documents Fee

6. Process Overview

1. To expedite study start up, the ideal time to utilize the LOI is upon notification of site selection.
2. The MUSC Principal Investigator’s (PI) Department will be responsible for:

2.1 Populating the Medical University of South Carolina (MUSC) Authorization for Regulatory / Research Billing Compliance Review Fee and Research Team Preparation of Regulatory & Compliance Submission Document Fees with the Date, Funding Entity, Protocol Title, Protocol Number, Principal Investigator information in the form fields.
2.2 The only other changes allowed to the LOI that do not require tracking and review by ORSP are any changes made to the amounts and items listed in the fee table.
2.3 The study team will submit the document in PDF form to the Funding Entity for signature.
2.4 If the Funding Entity requests to make changes to the LOI, the Funding Entity will be required to track requested changes and the study team must notify ORSP to begin the LOI review process with the Funding Entity.
2.5 Once the completed LOI document is returned to the MUSC study team, the Principal Investigator will sign and the study team will submit the document to the ORSP institutional signatory for full execution via electronic proposal routing.
2.6 The MUSC PI’s Department will be responsible for routing the electronic proposal associated with the LOI funds in order to trigger account set up.
2.7 Once the research contract is fully executed, the PI’s Department will email their ORSP administrator the revised internal budget including the newly negotiated study budget.

3. The MUSC Office of Research and Sponsored Programs will be responsible for:

3.1 Reviewing and negotiating the potential track changes to the LOI document requested by the Funding Entity.
3.2 Verifying that the tracked changes to the LOI are acceptable, accepting the changes and providing a PDF version of the document to the funding entity for signature.
3.3 Providing institutional signature once the Funding Entity and Investigator signatures have been obtained and providing the fully signed version to the Funding Entity and study
team.
3.4 Reviewing the electronic proposal associated with the LOI.
3.5 Updating ORSP financial systems with the finalized award information once the contract is fully executed.
3.6 Documenting that the LOI was utilized for reporting purposes.

4. If a research contract is fully executed:

4.1 The LOI becomes null and void once a CTA is executed.
4.2 The funds associated with the LOI should be included in the negotiated budget and the executed CTA.

5. If a research contract is never fully executed:

5.1 The department must wait until the IRB, OCR, or any other research implementation fees are charged before moving funds (less F & A) to a general research account.

6. Feedback on LOI implementation:

6.1 Please contact the Office of Clinical Research at ocrbudgeting@musc.edu or 843-792-7900 with feedback related to utilization of the LOI.